Health & Personal Care
CRITICAL
FDA DRUG
123Herbals SILINTAN 25-Pill Meloxicam Recall in 2026
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
123Herbals
Marketed Without
Brand hub
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.